Sep 08, 2022 / 08:00PM GMT
Operator
Greetings. Welcome to the Navidea Quarter 2 2022 Earnings Call and Business Update. (Operator Instructions) And please note that this conference is being recorded. I will now turn the conference over to Dr. Michael Rosol. Thank you, sir. You may begin.
Michael Stanley Rosol - Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer
Thank you, and thank you all for joining us here today. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. There is an accompanying slide deck that is also being displayed. Following prepared remarks, we will be conducting a live question-and-answer session. Navidea's Chair of its Board of Directors, Mr. Alex Cappello; its Vice Chair, Mr. Kim Scott; and its Vice President of Finance and Administration, Erika Eves, are joining me on the call today.
During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's
Q2 2022 Navidea Biopharmaceuticals Inc Earnings Call and Business Update Transcript
Sep 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers